Li-cheng Dai
Huzhou Key Laboratory of Molecular Medicine
Huzhou Central Hospital
Huzhou
Zhejiang Province
China
Name/email consistency: high
- In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles. Dai, L.C., Yao, X., Wang, X., Niu, S.Q., Zhou, L.F., Fu, F.F., Yang, S.X., Ping, J.L. World J. Gastroenterol. (2009)
- Midkine translocated to nucleoli and involved in carcinogenesis. Dai, L.C. World J. Gastroenterol. (2009)
- Midkine accumulated in nucleolus of HepG2 cells involved in rRNA transcription. Dai, L.C., Shao, J.Z., Min, L.S., Xiao, Y.T., Xiang, L.X., Ma, Z.H. World J. Gastroenterol. (2008)
- Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma. Dai, L.C., Wang, X., Yao, X., Lu, Y.L., Ping, J.L., He, J.F. World J. Gastroenterol. (2007)
- Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. Dai, L.C., Wang, X., Yao, X., Lu, Y.L., Ping, J.L., He, J.F. World J. Gastroenterol. (2007)
- Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model. Dai, L.C., Wang, X., Yao, X., Min, L.S., Ping, J.L., He, J.F. Acta Pharmacol. Sin. (2007)
- Antisense oligonucleotide targeting p53 increased apoptosis of MCF-7 cells induced by ionizing radiation. Dai, L.C., Wang, X., Yao, X., Min, L.S., Qian, F.C., He, J.F. Acta Pharmacol. Sin. (2006)
- Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells. Dai, L.C., Wang, X., Yao, X., Lu, Y.L., Ping, J.L., He, J.F. Acta Pharmacol. Sin. (2006)
- Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines. Dai, L.C., Xu, D.Y., Yao, X., Min, L.S., Zhao, N., Xu, B.Y., Xu, Z.P., Lu, Y.L. World J. Gastroenterol. (2006)